Evaluation of an Orally Administered Medication When Taken in Conjunction With Pramlintide

NCT00044707 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Non-Insulin-Dependent

Interventions

DRUG: Pramlintide acetate

Sponsor

AstraZeneca